Serdexmethylphenidate, discontinued (DEA controlled substance), is a sympathomimetic drug. Serdexmethylphenidate and dexmethylphenidate (trade name Azstarys) has been approved by FDA in 2021 to treat ADHD-attention deficit hyperactivity disorder.

纯度：≥98%

CAS：1996626-29-9